DM
Deerfield Management Portfolio holdings
AUM
$7.8B
1-Year Est. Return
76.63%
This Fund
S&P 500
1 Year Est. Return
+76.63%
AUM
$6.52B
AUM Growth
+$1.02B
(+18%)
Holding
173
Top Buys
| 1 | +$177M | |
| 2 | +$109M | |
| 3 | +$96.7M | |
| 4 |
Inspire Medical Systems
INSP
|
+$91.9M |
| 5 |
Cogent Biosciences
COGT
|
+$76M |
Top Sells
| 1 | +$250M | |
| 2 | +$74.9M | |
| 3 | +$47.7M | |
| 4 |
IDEAYA Biosciences
IDYA
|
+$42.6M |
| 5 |
United Therapeutics
UTHR
|
+$38.6M |
Sector Composition
| 1 | Healthcare | 91.92% |
| 2 | Real Estate | 0.38% |
| 3 | Financials | 0.07% |
| 4 | Consumer Staples | 0.07% |
| 5 | Consumer Discretionary | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Bio-Rad Laboratories Class A
BIO
$7.45B
| $63.4M | 0.97% |
226,070
|
|
||
27
Pharvaris
PHVS
$1.7B
| $60.9M | 0.93% |
2,442,464
+425,000
|
|
||
28
Disc Medicine
IRON
$2.43B
| $60.8M | 0.93% |
919,403
|
|
||
|
29
IDEAYA Biosciences
IDYA
$3.03B
| $58.6M | 0.9% |
2,153,043
-1,762,268
|
|
||
|
BBOT
30
BridgeBio Oncology
BBOT
$791M
| $56.6M | 0.87% |
+4,885,446
|
|
||
31
Envista
NVST
$4.66B
| $46.7M | 0.72% |
2,294,036
+78,191
|
|
||
32
Praxis Precision Medicines
PRAX
$8.83B
| $44.6M | 0.68% |
840,851
+153,920
|
|
||
33
CorMedix
CRMD
$544M
| $38.7M | 0.59% |
+3,323,833
|
|
||
34
Enhabit
EHAB
$687M
| $38M | 0.58% |
4,747,746
-32,118
|
|
||
35
Embecta
EMBC
$580M
| $37M | 0.57% |
2,620,421
-129,291
|
|
||
36
Celcuity
CELC
$4.9B
| $36.2M | 0.56% |
+733,530
|
|
||
37
CONMED
CNMD
$1.31B
| $35.8M | 0.55% |
760,196
+59,925
|
|
||
|
ZBIO
38
Zenas BioPharma
ZBIO
$1.33B
| $34.7M | 0.53% |
1,562,942
|
|
||
39
NeoGenomics
NEO
$1.18B
| $34.3M | 0.53% |
4,447,331
+2,299,331
|
|
||
40
Arrowhead Research
ARWR
$9.13B
| $34.2M | 0.52% |
+993,000
|
|
||
41
Day One Biopharmaceuticals
DAWN
$1.04B
| $33.2M | 0.51% |
4,705,413
+982,282
|
|
||
42
Kymera Therapeutics
KYMR
$7.01B
| $32.4M | 0.5% |
572,258
-80,742
|
|
||
43
CareDx
CDNA
$931M
| $31.9M | 0.49% |
+2,191,000
|
|
||
44
Alnylam Pharmaceuticals
ALNY
$42B
| $31M | 0.47% |
67,935
-77,065
|
|
||
45
Acadia Healthcare
ACHC
$2.02B
| $29.4M | 0.45% |
+1,189,000
|
|
||
|
SION
46
Sionna Therapeutics
SION
$1.47B
| $28.5M | 0.44% |
970,590
|
|
||
47
Savara
SVRA
$1.18B
| $28.4M | 0.44% |
7,964,000
|
|
||
48
Phreesia
PHR
$731M
| $26.3M | 0.4% |
1,116,752
+102,175
|
|
||
49
Veracyte
VCYT
$2.76B
| $24.9M | 0.38% |
726,000
+101,000
|
|
||
50
Ventas
VTR
$40.7B
| $24.8M | 0.38% |
354,000
|
|